BioinformaticsbioRxivPreprint
Computational Repurposing of FDA Approved Drugs Against Cyclin Dependent Kinase (CDK2)
The paper identifies FDA-approved drugs with potential binding activity against CDK2 using computational methods and selects Carteolol as a candidate.
DOI 10.64898/2026.10.27.762194